Antibody Diagnostics

ModiQuest founders developed the first diagnostics test for rheumatoid arthritis, marketed worldwide and included in the American College of Rheumatology (ACR) diagnostics criteria.

Antibody Therapeutics

ModiQuest's pipeline of preclinical candidates includes monoclonal and recombinant antibody therapeutics for prevention and treatment of established rheumatoid arthritis.

About ModiQuest

Experts in monoclonal and recombinant antibody generation for autoimmune and oncology, with high throughput hybridoma and phage display technology.

Latest News

• Immunoprecise Announces Oversubscription To Debenture Financing
• IMMUNOPRECISE ACQUIRES MODIQUEST RESEARCH BV
• Immunoprecies Antibodies Delivers Record Quarterly Revenue of $1.723 Million and Increases Gross Margins To 54%
• Immunoprecise enters into Definitive Agreement to Acquire ModiQuest Research BV